We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

First Postoperative Day Review After Uneventful Phacoemulsification

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01247155
Recruitment Status : Completed
First Posted : November 24, 2010
Last Update Posted : November 24, 2010
Sponsor:
Information provided by:
Veroia General Hospital

Brief Summary:
The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.

Condition or disease
Phacoemulsification Complications BCVA

Study Type : Observational
Observational Model: Case Control
Time Perspective: Prospective

Group/Cohort
first day review
non-first day review



Primary Outcome Measures :
  1. Best corrected visual acuity


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   65 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Sampling Method:   Probability Sample
Study Population
291 consecutive patients who underwent uneventful phacoemulsification cataract surgery were randomized into two groups: i) Next day review (NDR group, n=146) and ii) No next day review (NNDR group, n=145).
Criteria

Inclusion Criteria:

Exclusion Criteria:

Exclusion criteria were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01247155


Locations
Greece
General Hospital of Veroia
Veroia, Imathia, Greece, 59100
Sponsors and Collaborators
Veroia General Hospital

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01247155     History of Changes
Other Study ID Numbers: 9151
First Posted: November 24, 2010    Key Record Dates
Last Update Posted: November 24, 2010
Last Verified: April 2009